Farmatek Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.11 M
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Profit Growth -30.66%
- Ebitda -64.58%
- Net Worth -474.84%
- Total Assets %
About Farmatek
Farmatek Private Limited (FPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 1988 and has a history of 36 years and nine months. Its registered office is in Goa, Goa, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Prakash Kamatshankhwalkar, Vallabh Kamatshankhwalkar, and Gurudas Kamatshankhwalkar serve as directors at the Company.
Company Details
-
Location
Goa, Goa, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24232GA1988PTC000815
-
Company No.
000815
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 1988
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Goa
Industry
Who are the key members and board of directors at Farmatek?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Kamatshankhwalkar
|
Managing Director | 19-Apr-1988 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Vallabh Kamatshankhwalkar
|
Director | 19-Apr-1988 | Current |
|
Gurudas Kamatshankhwalkar
|
Director | 19-Apr-1988 | Current |
Financial Performance of Farmatek.
Farmatek Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 30.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 474.84%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Farmatek?
Unlock access to Farmatek's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Farmatek?
Unlock and access historical data on people associated with Farmatek, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Farmatek, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Farmatek's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.